Literature DB >> 12602903

Cell proliferation, apoptosis, and expression of Bcl-2 and Bax in non-lactating human breast epithelium in relation to the menstrual cycle and reproductive history.

F Feuerhake1, W Sigg, E A Höfter, P Unterberger, U Welsch.   

Abstract

Cell proliferation, apoptosis, and the expression of Bcl-2 and Bax were investigated in breast tissue of healthy premenopausal women in order to study the effect of the menstrual cycle and reproductive history on the cell turnover in the non-lactating mammary gland epithelium. Immunohistochemistry was used to detect the proliferation-associated antigen Ki-67, as well as Bcl-2 and Bax. Apoptotic cells were identified by enzymatic labelling of fragmentized DNA (TUNEL-technique) and morphologic analysis. Consistent with published data, the proliferative activity and the frequency of apoptotic events as detected by morphologic analysis was higher in the luteal than in the follicular phase of the menstrual cycle. Parity, lactation, and age correlated with lower proliferative activity, whereas the frequency of apoptosis was not significantly influenced by the reproductive history. Staining patterns for Bax and Bcl-2 showed characteristic changes due to the menstrual cycle with a maximum of immunoreactivity for Bcl-2 in the follicular phase and for Bax in the luteal phase. However, there was no statistically significant association between Bcl-2/Bax immunoreactivity and menstrual cycle or reproductive parameters. We conclude that other molecular pathways than the Bax/Bcl-2 antagonism may additionally be involved in the regulation of apoptotic cell death in the breast epithelium. Knowledge of the entire complexity of apoptosis regulation is necessary to understand the observed effects of parity and lactation on mammary epithelial biology, and possibly to be able to influence pathological processes caused by an imbalance between cell renewal and elimination.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12602903     DOI: 10.1023/a:1021119830269

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle.

Authors:  Alana R Amarosa; Jason McKellop; Ana Paula Klautau Leite; Melanie Moccaldi; Tess V Clendenen; James S Babb; Anne Zeleniuch-Jacquotte; Linda Moy; Sungheon Kim
Journal:  Radiology       Date:  2013-05-08       Impact factor: 11.105

2.  Accuracy of screening mammography varies by week of menstrual cycle.

Authors:  Diana L Miglioretti; Rod Walker; Donald L Weaver; Diana S M Buist; Stephen H Taplin; Patricia A Carney; Robert D Rosenberg; Mark B Dignan; Zhuo Tracy Zhang; Emily White
Journal:  Radiology       Date:  2010-12-03       Impact factor: 11.105

3.  Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial.

Authors:  Linda Hovanessian-Larsen; DeShawn Taylor; Debra Hawes; Darcy V Spicer; Michael F Press; Anna H Wu; Malcolm C Pike; C Leigh Pearce
Journal:  Contraception       Date:  2012-02-09       Impact factor: 3.375

4.  The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.

Authors:  Sung Jin Huh; Hannah Oh; Michael A Peterson; Vanessa Almendro; Rong Hu; Michaela Bowden; Rosina L Lis; Maura B Cotter; Massimo Loda; William T Barry; Kornelia Polyak; Rulla M Tamimi
Journal:  Cancer Res       Date:  2016-03-03       Impact factor: 12.701

5.  Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer.

Authors:  Chun Huang; Xuan Wang; Baocun Sun; Man Li; Xiulan Zhao; Yanjun Gu; Yanfen Cui; Yan Li
Journal:  Target Oncol       Date:  2014-05-17       Impact factor: 4.493

6.  Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.

Authors:  Anne Grote; Mahmoud Abbas; Nina Linder; Hans H Kreipe; Johan Lundin; Friedrich Feuerhake
Journal:  Diagn Pathol       Date:  2014-12-19       Impact factor: 2.644

7.  Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study.

Authors:  Vinay Singhal; J P Singh; Ashima Lyall; Sunita Saxena; Anju Bansal
Journal:  BMC Cancer       Date:  2004-08-13       Impact factor: 4.430

8.  In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium.

Authors:  J C L Alfonso; N S Schaadt; R Schönmeyer; N Brieu; G Forestier; C Wemmert; F Feuerhake; H Hatzikirou
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

9.  Association of reproductive history with breast tissue characteristics and receptor status in the normal breast.

Authors:  Marike Gabrielson; Flaminia Chiesa; Catharina Behmer; Katarina Rönnow; Kamila Czene; Per Hall
Journal:  Breast Cancer Res Treat       Date:  2018-03-30       Impact factor: 4.872

10.  Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers.

Authors:  Mihriban Karaayvaz-Yildirim; Rebecca E Silberman; Adam Langenbucher; Srinivas Vinod Saladi; Kenneth N Ross; Elena Zarcaro; Andrea Desmond; Murat Yildirim; Varunika Vivekanandan; Hiranmayi Ravichandran; Ravindra Mylavagnanam; Michelle C Specht; Sridhar Ramaswamy; Michael Lawrence; Angelika Amon; Leif W Ellisen
Journal:  Sci Adv       Date:  2020-01-29       Impact factor: 14.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.